Marketing In Brief
This article was originally published in The Rose Sheet
Executive Summary
Swell Skin: "Minimalist" skin-care line consists of just two products - "a chunky bar of soap and face oil" - that harness the "healing properties" of sea buckthorn to address 90% of skin's needs, according to company founded by homeopath Kelli Klus. Formulated with aloe vera, vitamin E and coconut oil in addition to sea buckthorn, Swell Face Treatment ($32 for 3.5-oz. bar) cleanses and helps to combat acne, rosacea and dermatitis while promoting more youthful skin, Swell Skin claims. Meanwhile, Swell Oil of Sea Buckthorn ($22 for 0.05 oz. bottle), featuring 100% pure oil derived from seed of the sea buckthorn berry, protects and nourishes skin with 190 bioactive ingredients, 42 lipids and 22 fatty acids, including Omega 7. Line "seeks to simplify the beauty routines of the millions of women who were taught that they need a multitude of products to achieve healthy skin," allowing the consumer "to clutter your bank account with savings while un-cluttering your bathroom of unnecessary beauty products," company says. Products are available at SwellSkin.net. Sibu Beauty has built its skin-care line around sea buckthorn sourced from the Himalayas in Tibet (1"The Rose Sheet" April 5, 2010)
You may also be interested in...
Sibu Launches New Topical Products While Raising Sea-Buckthorn Awareness
Sibu Beauty is launching three new topical products - with plans for further line extensions - while working to raise awareness of its brand and core ingredient, the "superfood" sea buckthorn
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle